Related Experiment Videos
Effects of dopamine and adrenaline infusions in severe infection
Lancet (London, England)
|October 19, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Surgery of sublingual and minor salivary gland cancer: REFCOR recommendations by the formal consensus method.
European annals of otorhinolaryngology, head and neck diseases·2023
Surgery of major salivary gland cancers: REFCOR recommendations by the formal consensus method.
European annals of otorhinolaryngology, head and neck diseases·2023
Lymph node surgery for salivary gland cancer: REFCOR recommendations by the formal consensus method.
European annals of otorhinolaryngology, head and neck diseases·2023
Diagnostic imaging of salivary gland cancers: REFCOR recommendations by the formal consensus method.
European annals of otorhinolaryngology, head and neck diseases·2023
Post-treatment monitoring of salivary gland cancer: REFCOR recommendations by the formal consensus method.
European annals of otorhinolaryngology, head and neck diseases·2023
Most-favoured-nation pricing for prescription drugs in US Medicare: a cohort study.
Lancet (London, England)·2026
Wildfire smoke and health: current evidence, mechanisms, and future challenges.
Lancet (London, England)·2026
TvTPPIMI: A Boundary-Aware Dual-View Framework for Predicting PPI-Modulator Interactions.
Journal of chemical information and modeling·2026
MMU-DPI: Enhancing Generalization in Drug-Protein Interaction Prediction through Multimodal Learning and a Label Mix Strategy.
Journal of chemical information and modeling·2026
TogoPhosTAC as a delivery-ready platform for targeted protein dephosphorylation.
Nature communications·2026
The shake-test for adjuvanted vaccines: A manufacturer's perspective.
Journal of pharmaceutical sciences·2026
Zhangyanming Tablets for Dry Eye Disease: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study.
Chinese journal of integrative medicine·2026
Doravirine/Islatravir: First Approval.
Drugs·2026